Clinical trial
Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve…
NCT00359489 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00359489 |
|---|---|
| Title | Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People. |
| Official title | A Randomized, Open-Label, Methodology Trial To Investigate The Utility Of Echocardiography In Assessment Of Cardiac Valvular Regurgitation In Adult Subjects |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Heart Valve Diseases |
| Intervention type | Device |
| Interventions | cardiac echosonography |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Aug 2, 2006 |
| Last update posted | Sep 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: